New health care policy changes will soon affect weight-loss drugs
Novo Nordisk (NVO) and Eli Lilly (LLY) manufacture the top three weight loss drugs on the market, but heightened demand is ...
Hosted on MSN16d
Currax is benefitting from weight loss drug demand, says CEO George Hampton
George Hampton, Currax CEO, joins CNBC's 'The Exchange' to discuss the company's weight loss drugs, how Contrave differs from other offerings, and more. Kamala Harris Could Break 32-Year Record in ...